First Time Loading...

Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211

Watchlist Manager
Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Watchlist
Price: 38.7 CNY -0.9%
Updated: May 14, 2024

Operating Margin
Tibet Rhodiola Pharmaceutical Holding Co

39.1%
Current
24%
Average
4.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
39.1%
=
Operating Profit
1.2B
/
Revenue
3.1B

Operating Margin Across Competitors

Country CN
Market Cap 12.5B CNY
Operating Margin
39%
Country US
Market Cap 72.1B USD
Operating Margin
1%
Country US
Market Cap 44.4B USD
Operating Margin
1%
Country US
Market Cap 35.4B USD
Operating Margin
1%
Country US
Market Cap 23.9B USD
Operating Margin
1%
Country US
Market Cap 9.4B USD
Operating Margin
5%
Country KR
Market Cap 12.2T KRW
Operating Margin
9%
Country CN
Market Cap 69.4B HKD
Operating Margin
4%
Country CN
Market Cap 59.9B CNY
Operating Margin
9%
Country IT
Market Cap 7.6B EUR
Operating Margin
12%
Country CN
Market Cap 52B CNY
Operating Margin
3%

Profitability Report

View the profitability report to see the full profitability analysis for Tibet Rhodiola Pharmaceutical Holding Co.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
39.1%
=
Operating Profit
1.2B
/
Revenue
3.1B
What is the Operating Margin of Tibet Rhodiola Pharmaceutical Holding Co?

Based on Tibet Rhodiola Pharmaceutical Holding Co's most recent financial statements, the company has Operating Margin of 39.1%.